CN109432275A - A kind of Chinese medicine composition and preparation method thereof for treating gynaecological disease - Google Patents
A kind of Chinese medicine composition and preparation method thereof for treating gynaecological disease Download PDFInfo
- Publication number
- CN109432275A CN109432275A CN201811547107.2A CN201811547107A CN109432275A CN 109432275 A CN109432275 A CN 109432275A CN 201811547107 A CN201811547107 A CN 201811547107A CN 109432275 A CN109432275 A CN 109432275A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- preparation
- sulphur
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 79
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 31
- 201000010099 disease Diseases 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims description 20
- 229910021538 borax Inorganic materials 0.000 claims abstract description 28
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 28
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 28
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 24
- 239000009969 fructus bruceae Substances 0.000 claims abstract description 24
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 23
- 244000205574 Acorus calamus Species 0.000 claims abstract description 22
- 235000011996 Calamus deerratus Nutrition 0.000 claims abstract description 22
- 241000605422 Asparagus asparagoides Species 0.000 claims abstract description 20
- 241000218682 Pseudolarix amabilis Species 0.000 claims abstract description 20
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 5
- 241000558306 Gynocardia odorata Species 0.000 claims abstract 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 34
- 239000005864 Sulphur Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 22
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 22
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 22
- 229940116229 borneol Drugs 0.000 claims description 22
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 22
- 229940079593 drug Drugs 0.000 claims description 22
- 241000723346 Cinnamomum camphora Species 0.000 claims description 21
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 19
- 229930008380 camphor Natural products 0.000 claims description 19
- 229960000846 camphor Drugs 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 19
- 229910052957 realgar Inorganic materials 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 230000036961 partial effect Effects 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 235000001667 Vitex agnus castus Nutrition 0.000 claims 2
- 244000063464 Vitex agnus-castus Species 0.000 claims 2
- 238000007654 immersion Methods 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 21
- 206010046901 vaginal discharge Diseases 0.000 abstract description 6
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 abstract description 5
- 201000005630 leukorrhea Diseases 0.000 abstract description 5
- 208000006379 syphilis Diseases 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 208000006374 Uterine Cervicitis Diseases 0.000 abstract description 3
- 206010046914 Vaginal infection Diseases 0.000 abstract description 3
- 201000008100 Vaginitis Diseases 0.000 abstract description 3
- 206010008323 cervicitis Diseases 0.000 abstract description 3
- 208000001688 Herpes Genitalis Diseases 0.000 abstract description 2
- 230000003628 erosive effect Effects 0.000 abstract description 2
- 201000004946 genital herpes Diseases 0.000 abstract description 2
- 208000011580 syndromic disease Diseases 0.000 abstract description 2
- 201000010260 leiomyoma Diseases 0.000 abstract 1
- 241001570521 Lonicera periclymenum Species 0.000 description 18
- 241001179022 Hydnocarpus anthelminthicus Species 0.000 description 16
- 230000006870 function Effects 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 206010063409 Acarodermatitis Diseases 0.000 description 7
- 241000447727 Scabies Species 0.000 description 7
- 208000005687 scabies Diseases 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 206010010071 Coma Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 238000001784 detoxification Methods 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 240000000774 Cunila origanoides Species 0.000 description 3
- 235000018274 Cunila origanoides Nutrition 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 235000014866 Dictamnus albus Nutrition 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- WITLAWYGGVAFLU-UHFFFAOYSA-N 3-(6-methoxy-1,3-benzodioxol-5-yl)-8,8-dimethylpyrano[2,3-f]chromen-4-one Chemical compound C1=CC(C)(C)OC2=CC=C(C(C(C3=CC=4OCOC=4C=C3OC)=CO3)=O)C3=C21 WITLAWYGGVAFLU-UHFFFAOYSA-N 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 240000000233 Melia azedarach Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 235000004443 Ricinus communis Nutrition 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- -1 acetaldehyde potassium chloride Chemical compound 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000009172 bursting Effects 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- XQINTCORIZHGFD-UHFFFAOYSA-O 1,2,10-trimethoxy-6,6-dimethyl-5,6,6a,7-tetrahydro-4h-dibenzo[de,g]quinoline-6-ium-11-ol Chemical compound C1=C(OC)C(OC)=C2C3=C(O)C(OC)=CC=C3CC3[N+](C)(C)CCC1=C23 XQINTCORIZHGFD-UHFFFAOYSA-O 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- AUNAUZZQBAIQFJ-UHFFFAOYSA-N 2,4,5-Trimethoxy-1-allylbenzene Chemical compound COC1=CC(OC)=C(OC)C=C1CC=C AUNAUZZQBAIQFJ-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- UNHHWEHQUUGKEE-MLLLWRCASA-N Amurensin Chemical compound C1=C(O)C(C(C(O)=C(O2)C=3C=CC(O)=CC=3)=O)=C2C(CCC(C)(O)C)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UNHHWEHQUUGKEE-MLLLWRCASA-N 0.000 description 1
- HDQHRTXBXYQUNW-CABCVRRESA-N Amurensine Natural products O(C)c1c(O)cc2[C@H]3c4c(cc5OCOc5c4)C[C@H](N(C)C3)c2c1 HDQHRTXBXYQUNW-CABCVRRESA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241001435059 Artemisia argyi Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 240000000572 Blumea balsamifera Species 0.000 description 1
- IRQXZTBHNKVIRL-GOTQHHPNSA-N Bruceantin Chemical compound CC1=C(O)C(=O)C[C@]2(C)[C@@H]([C@@H](O)[C@@H]3O)[C@@]45CO[C@@]3(C(=O)OC)[C@@H]5[C@@H](OC(=O)\C=C(/C)C(C)C)C(=O)O[C@@H]4C[C@H]21 IRQXZTBHNKVIRL-GOTQHHPNSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 241001299817 Dictamnus Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241000931143 Gleditsia sinensis Species 0.000 description 1
- 206010018693 Granuloma inguinale Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 241000292343 Hydnocarpus hainanensis Species 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- MXTLAHSTUOXGQF-UHFFFAOYSA-O Jatrorrhizine Chemical compound COC1=CC=C2C=C3C(C=C(C(=C4)O)OC)=C4CC[N+]3=CC2=C1OC MXTLAHSTUOXGQF-UHFFFAOYSA-O 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 244000062241 Kaempferia galanga Species 0.000 description 1
- 235000013421 Kaempferia galanga Nutrition 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 241001215120 Leptospirales Species 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- 241001500894 Lonicera fulvotomentosa Species 0.000 description 1
- 241001170080 Lonicera hypoglauca Species 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- IRQXZTBHNKVIRL-UHFFFAOYSA-N NSC 165563 Natural products CC1=C(O)C(=O)CC2(C)C(C(O)C3O)C45COC3(C(=O)OC)C5C(OC(=O)C=C(C)C(C)C)C(=O)OC4CC21 IRQXZTBHNKVIRL-UHFFFAOYSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241001079007 Phellodendron chinense Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 240000003085 Quassia amara Species 0.000 description 1
- 235000009694 Quassia amara Nutrition 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 241000758742 Saururaceae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000362909 Smilax <beetle> Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000224526 Trichomonas Species 0.000 description 1
- 208000016599 Uterine disease Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241000746966 Zizania Species 0.000 description 1
- 235000002636 Zizania aquatica Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- UNHHWEHQUUGKEE-UHFFFAOYSA-N amurensin Natural products C1=C(O)C(C(C(O)=C(O2)C=3C=CC(O)=CC=3)=O)=C2C(CCC(C)(O)C)=C1OC1OC(CO)C(O)C(O)C1O UNHHWEHQUUGKEE-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FDABVSXGAMFQQH-XZWHSSHBSA-N berbamunine Chemical compound CN1CCC2=CC(OC)=C(O)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@@H]2N(C)CCC=3C=C(C(=CC=32)O)OC)=C1 FDABVSXGAMFQQH-XZWHSSHBSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001642 boronic acid derivatives Chemical group 0.000 description 1
- IRQXZTBHNKVIRL-AYXPYFKUSA-N bruceantin Natural products CC1=C(O)C(=O)C[C@]2(C)[C@@H]([C@@H](O)[C@@H]3O)[C@@]45CO[C@@]3(C(=O)OC)[C@@H]5[C@@H](OC(=O)C=C(C)C(C)C)C(=O)O[C@@H]4C[C@H]21 IRQXZTBHNKVIRL-AYXPYFKUSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 201000006901 congenital syphilis Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- FJSOHLNMRNSYFR-OPDZODGYSA-N epimedoside C Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(C/C=C(\C)/C)c2OC(c3ccc(O)cc3)=C(O)C(=O)c2c(O)c1 FJSOHLNMRNSYFR-OPDZODGYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 208000011404 female reproductive system disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000017708 myomatous neoplasm Diseases 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 208000015124 ovarian disease Diseases 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229940013788 quassia Drugs 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 208000017443 reproductive system disease Diseases 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 125000000101 thioether group Chemical group 0.000 description 1
- 208000009189 tinea favosa Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 208000013464 vaginal disease Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- USMNOWBWPHYOEA-MRTMQBJTSA-N α-thujone Chemical compound O=C([C@@H]1C)C[C@@]2(C(C)C)[C@@H]1C2 USMNOWBWPHYOEA-MRTMQBJTSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of for treating the Chinese medicine composition of gynaecological disease, including following components according to parts by weight: 100~200 parts of honeysuckle, 100~200 parts of cordate houttuynia, 100~200 parts of spina gleditsiae, 100~200 parts of kuh-seng, 100~200 parts of smilax, 100~200 parts of Cortex Phellodendri, 100~200 parts of calamus, 50~150 parts of folium artemisiae argyi, 50~150 parts of Fructus Bruceae, 100~200 parts of Fructus meliae toosendan, 50~150 parts of Golden Larch Bark, 50~150 parts of cortex dictamni, 50~150 parts of chaulmoogra, 50~150 parts of borax.The Chinese medicine composition, which can treat gynaecological imflammation, vaginitis, cervicitis, pelvic inflammatory disease, fibroid, tumour, erosion, yellowish leukorrhea, leukorrhea, peculiar smell, gynecologic miscellaneous diseases and men and women's venereal disease, such as genital herpes, syphilis, stranguria syndrome etc., definite curative effect.
Description
Technical field
The present invention relates to technical field of Chinese medicine, and in particular to and it is a kind of for treating the Chinese medicine composition of gynaecological disease, and
The preparation method of the Chinese medicine composition.
Background technique
The disease of female reproductive system is gynecological disease, including vulva disease, vaginal disease, uterine disease, fallopian tubal
Disease, disease of ovary etc..Common illness include irregular menstruation, dysmenorrhea, adnexitis, pelvic inflammatory disease, cervicitis, endometritis,
Vaginal discharge has peculiar smell etc., and some even causes infertile.Gynecological disease is women common disease, frequently-occurring disease.But by
Due understanding is lacked to gynecological disease in many people, lacks the health care to body, various bad life habits etc., make in addition
Physiological health go fromes bad to worse, and causes some women's diseases to be burdened with, and obstinate, comes to normal life, work belt great
It is inconvenient.
Treatment gynaecologic reproductive system disease method is more at present, and wherein surgical result is most obvious.But this operation one
As risk it is high, surgery cost is high, and patient is generally unwilling to use, and Chinese medicine emphasizes dialectical treatment, and majority carries out group using Chinese herbal medicine
It closes, is treated by way of for oral administration or external application.This therapeutic effect is slow, but can also cure, and more patient is easy to connect
By.
Since gynaecological disease has the characteristics that generality, diversity, complication, need to develop it is a can a medicine it is multi-purpose, again
Treatment, prevention, maintenance action, and wide spectrum gynecologic medicine easy to carry and convenient to use can safely and efficiently be played.
In consideration of it, the present invention is specifically proposed.
Summary of the invention
The first object of the present invention is to provide a kind of for treating the Chinese medicine composition of gynaecological disease.
The second object of the present invention is to provide the preparation method of above-mentioned gynaecological disease composition.
To achieve the above object, technical scheme is as follows:
The present invention relates to a kind of for treating the Chinese medicine composition of gynaecological disease, including following components according to parts by weight:
100~200 parts of honeysuckle, 100~200 parts of cordate houttuynia, 100~200 parts of spina gleditsiae, 100~200 parts of kuh-seng, smilax 100
~200 parts, 100~200 parts of Cortex Phellodendri, 100~200 parts of calamus, 50~150 parts of folium artemisiae argyi, 50~150 parts of Fructus Bruceae, Fructus meliae toosendan
100~200 parts, 50~150 parts of Golden Larch Bark, 50~150 parts of cortex dictamni, 50~150 parts of chaulmoogra, 50~150 parts of borax.
The invention further relates to the preparation methods of the Chinese medicine composition, comprising the following steps:
(1) by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng, smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan,
After Golden Larch Bark, cortex dictamni and chaulmoogra mixing, add water to cook to obtain medical fluid；
(2) borax is added in Xiang Suoshu medical fluid, continues to boil paste making agent.
Preferably, the weight ratio of the water and drug component is 1:(3~5).
Preferably, the decoction step include: into drug component be added water impregnate 2~3 hours after, intense fire fried 4~
It 10 minutes, then decocts with slow fire 80~120 minutes.
Preferably, the Chinese medicine composition also contains following components according to parts by weight: 50~150 parts of sulphur, realgar
10~100 parts, 5~30 parts of camphor, 5~30 parts of borneol.
Preferably, the Chinese medicine composition includes following components according to parts by weight: 150 parts of honeysuckle, cordate houttuynia
150 parts, 150 parts of spina gleditsiae, 150 parts of kuh-seng, 150 parts of smilax, 150 parts of Cortex Phellodendri, 150 parts of calamus, 100 parts of folium artemisiae argyi, Fructus Bruceae
It is 100 parts, 150 parts of Fructus meliae toosendan, 100 parts of Golden Larch Bark, 100 parts of cortex dictamni, 100 parts of chaulmoogra, 100 parts of borax, 100 parts of sulphur, male
It is 60 parts, 15 parts of camphor, 15 parts of borneol yellow.
The invention further relates to the preparation methods of the Chinese medicine composition, comprising the following steps:
(1) by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng, smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan,
After Golden Larch Bark, cortex dictamni and chaulmoogra mixing, add water to cook to obtain medical fluid；
(2) male sulphur, sulphur, borax, camphor and borneol after grinding are added in Xiang Suoshu medical fluid, boils paste making agent.
Preferably, the weight ratio of the water and drug component is 1:(3~5).
Preferably, by after the male sulphur, sulphur, borax, camphor and borneol and grinding, partial size≤100 mesh particle is obtained.
Preferably, the decoction step include: into drug component be added water impregnate 2~3 hours after, intense fire fried 4~
It 10 minutes, then decocts with slow fire 80~120 minutes.
Beneficial effects of the present invention:
Chinese medicine composition provided by the invention can treat gynaecological imflammation, vaginitis, cervicitis, pelvic inflammatory disease, uterus muscle
Tumor, tumour, erosion, yellowish leukorrhea, leukorrhea, peculiar smell, gynecologic miscellaneous diseases and men and women's venereal disease, such as genital herpes, syphilis, stranguria syndrome etc. are
There is definite curative effect.In addition, also having preferable therapeutic effect to bite by mosquitos, sore, tinea, scabies, itch and red mouth wound, scald.
Specific embodiment
To make the object, technical solutions and advantages of the present invention clearer, technical solution of the present invention will be carried out below
Detailed description.Obviously, described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.Base
Embodiment in the present invention, those of ordinary skill in the art obtained institute without making creative work
There is other embodiment, belongs to the range that the present invention is protected.
The present embodiments relate to a kind of for treating the Chinese medicine composition of gynaecological disease, including according to parts by weight with
Lower component: 100~200 parts of honeysuckle, 100~200 parts of cordate houttuynia, 100~200 parts of spina gleditsiae, 100~200 parts of kuh-seng, soil
100~200 parts of Poria cocos, 100~200 parts of Cortex Phellodendri, 100~200 parts of calamus, 50~150 parts of folium artemisiae argyi, 50~150 parts of Fructus Bruceae,
100~200 parts of Fructus meliae toosendan, 50~150 parts of Golden Larch Bark, 50~150 parts of cortex dictamni, 50~150 parts of chaulmoogra, borax 50~150
Part.
There is synergistic effect between each ingredient of Chinese materia medica preparation of the present invention, have for all kinds of gynecological diseases and significantly control
Therapeutic effect has no toxic side effect.The curative effect of specific each ingredient is as follows:
Honeysuckle is Caprifoliaceae woodbine honeysuckle Lonicera japonica Thunb., Lonicera confusa
Lonicera confusa (Sweet) DC., wild rice gland honeysuckle Lonicera hypoglauca Miq., fulvoushair honeysuckle flower
The bud of Lonicera fulvotomentosa Hsu et S.C.Cheng.There is the effect of clearing heat and detoxicating.Cure mainly exogenous disease wind
Heat or warm disease heating, heatstroke, toxic-heat and blood stasis, carbuncle swells furunculosis, sore throat, multi-infection disease.Modern medicine proves, honeysuckle
Containing volatile oil, flavonoids (luteolin), saponin, inositol etc..With broad-spectrum antibacterial action, to staphylococcus aureus, white
Staphylococcus, male beta hemolytic streptococcus, anhemolytic streptococcus, typhoid fever, dysentery, tubercle bacillus, Diplococcus pneumopniae etc. have
Inhibiting effect.It can reduce the activity of carcinogenic substance peroxidase and cholinesterase.
Cordate houttuynia is the dry aerial parts cordate houttuynia acrid flavour of saururaceae plant houttuynia cordata, cold, distributed in lung channel.It can be clear
Sore, promoting urination and removing dampness, clearing away heat to cure dysentery, stomach strengthening and digestion promoting are treated in thermal detoxification, detumescence, are the lung suffered from for controlling real heat, heat toxin, damp evil, disease heat
Carbuncle, sore swollen toxin, hemorrhoidal hemorrhage, retention of heat in the spleen and stomach etc..Modern medicine proves, cordate houttuynia containing quercitrin, decanoy acetaldehyde potassium chloride,
Potassium sulfate, cordarine etc..There is apparent inhibiting effect to micrococcus catarrhalis, Bacillus influenzae, Diplococcus pneumopniae, staphylococcus.Have clear
Thermal detoxification, detumescence and apocenosis, inducing diuresis for treating strangurtia function.
Spina gleditsiae is the drying quil of leguminous plant Chinese honey locust Gleditsia sinensis Lam..With detumescence and poison retention,
The effect of apocenosis, desinsection.Be usually used in ulcer from the beginning of or purulence at not bursting；Castor is controlled outside.Modern medicine proves that spina gleditsiae contains
Flavones ingredient has antitumaous effect, has inhibiting effect to sarcoma180, and the inhibiting effect to JTC-26 is 50-70%.
Kuh-seng is the dry root of leguminous plant kuh-seng.It is bitter, trembles with fear.There are heat-clearing and damp-drying drug, desinsection, the function of diuresis.For heat
Dysentery, hematochezia, jaundice urodialysis, leukorrhea with reddish discharge, swelling of vulva pruritus vulvae, eczema, wet sore, pruitus, castor control trichomonas yin outside
Road is scorching.Modern medicine proves that kuh-seng is containing matrine, oxymatrine, sophoranl, flavonoids etc..There is anti-Amoeba to make
With, have and repel different quinidine-like action, has apparent inhibiting effect to transplantable tumor 180, there is apparent function of increasing leukocyte,
There are heat-clearing, eliminating dampness, desinsection, diuresis function
Smilax is the dry rhizome of liliaceous plant smilacis glabra.It is sweet in flavor, light, it is mild-natured.There is removing toxic substances, dehumidifies, tonneau
The effect of joint, is mainly used for limbs muscular constricture, arthralgia and myalgia caused by syphilis and mercury poisoning；Damp and hot stranguria with turbid discharge, leukorrhagia, carbuncle swells, scrofula
Scrofula, scabies.Modern medicine proves that smilax is containing saponin, tannin, resin, volatile oil, alkaloid, polysaccharide etc..Kill a day hook end
Conveyor screw effect has good therapeutic effect to congenital syphilis and existing disease syphilis, has dehumidifying, removing toxic substances, easing joint movement function to make.
Cortex Phellodendri is the dry bark of rutaceae wampee Phellodendron chinense Schneid..Taste
Hardship, it is cold in nature.There is the effect of heat-clearing and damp-drying drug, purging intense heat, except steaming, detoxification sore treatment.Modern medicine proves that Cortex Phellodendri contains a variety of alkaloids,
In have jamaicin, menispermine, magnoline, jateorrhizine and amurensin etc..Have bacteriostasis, to white containing coccus, Escherichia coli,
Typhoid bacillus, comma bacillus have killing effect, to fishing Leptospiral to have inhibiting effect, can enhance white blood cell phagocytic activity, have pair
Anti- acetyl alkali effect, there is protection blood platelet, has blood pressure lowering, blood glucose effect, has anti-inflammatory effect, have excited smooth muscle to act on, has clear
Hot eliminating dampness, purging intense heat, except steaming, detoxification sore treatment function.
Calamus also known as rhizoma acori graminei have the effect of dampness elimination appetizing, slit phlegm of having one's ideas straightened out, inducing resuscitation intelligence development.For gastral cavity ruffian is not hungry, keep silent
Mouth diarrhea, coma epilepsy, forgetfulness and deafness.Qi-regulating, promoting blood circulation, relieve heat are dried.Epilepsy is controlled, coma due to blocking of the respiratory system, pyreticosis coma, amnesia is gas-tight
Deafness, ambition is unhappy, stomachache, abdominal pain, wind-cold-dampness arthralgia, swollen ulcer drug, traumatic injury.Modern medicine proves that calamus contains asarum
Ether, carypohyllene, Humuleno, sekishone, amino acid, carbohydrate, organic acid etc..Ascites cells can be killed, are caused a disease to common skin
Fungi has different inhibiting effect, there is dampness elimination slit phlegm, inducing resuscitation intelligence development functions.
Folium artemisiae argyi, Chinese medicine name.For the dried leaf of compositae plant Chinese mugwort Artemisia argyi Levl.et Vant..Nature and flavor
It is pungent, bitter, temperature.Liver,spleen,kidney is returned to pass through.With warming channel for arresting bleeding, eliminating cold to stop pain；The effect of external application removing dampness to stop itchin.Modern medicine proves,
Folium artemisiae argyi is containing eucalyptol, absinthol, half terpenes of letter, thujanol, choline, vitamin A etc..To streptococcus, staphylococcus aureus,
Corynebacterium diphtheriae has inhibiting effect, has inhibiting effect to common skin pathomycete, there is eliminating cold to stop pain, warming channel for arresting bleeding function.
Fructus Bruceae is the mature seed of quassia Fructus Bruceae tree.Major function are as follows: control dysentery, antimalarial.For protracted dysentery,
Recurrent dysentery, malaria.Modern medicine proves, the fatty oil of Fructus Bruceae, alkaloid, phenolic constituent, Fructus Bruceae acid, Bruceantin, duck
Courage alcohol etc..Have and kill Amoeba and antitumaous effect, local organization degeneration can be made downright bad, had antihypertensive effect, has clear
Thermal detoxification, corrosion wart function.
Fructus meliae toosendan is the dry mature fruit of Meliaceae plant melia toosendan MeLia toosendan Sieb.et Zucc..Property
Bitter is trembled with fear.Return liver, small intestine, bladder meridian.For liver depression forming fire, chest side of body, abdominal distention, hernia pain, abdominal pain due to enterositosis.Modern times doctor
Learning proves, Fructus meliae toosendan is containing chinaberry element, alkaloid, kaempferia galanga alkali, resin, tannin etc..To staphylococcus aureus, Escherichia coli, chicken embryo
Virus has inhibiting effect, there is easypro liver, promoting the circulation of qi, analgesic, function for expelling pests.
Golden Larch Bark, be pinaceae plant golden larch Pseudolarix amabilis (Nelson) Rehd. dry root skin or
Near root bark.Acrid flavour, it is warm-natured.With desinsection, treat tinea, it is antipruritic the effect of.It is usually used in scabies itch.
Cortex dictamni also known as dittany bark are the root skin of Rutaceae herbaceos perennial shaggy-fruited dittany and Dictamnus angustifolius.Modern times doctor
Learning proves, cortex dictamni alkali containing cortex dictamni, shaggy-fruited dittany lactones, sitosterol, Hu reed alkali, obacunonic acid, dasycarpamin etc..To a variety of causes
Sick fungi has inhibiting effect, has the effect of heat-clearing and damp-drying drug, wind-dispelling is detoxified.Damp and hot sore is cured mainly, yellow water is dripping, eczema, wind
Rash, scabies sore leprosy, beriberoid pyretic arthralgia.
Chaulmoogra, Chinese medicine name.For Flacourtiaceae plant chaulmoogra Hydnocarpus anthelmintica Pierre,
The mature seed of Hainan chaulmoogra Hydnocarpus hainanensis (Merr.) Sleum.Acrid flavour, property heat.Return liver, the spleen channel.
With dispelling pathogenic wind and remove dampness, the effect of detoxicating and destroying parasites.It is usually used in leprosy, syphilis, scabies, wine Zha nose, acne.
Borax is borate family borax race mineral borax Borax.It is sweet in flavor, salty, it is cool in nature.It attaches to the lung and stomach meridians.Disappear with heat-clearing
The effect of phlegm, detoxifying and anticorrosive.It is for oral administration, control phlegm-heat cough and dysphagic accumulation, all bone sticking larynxs；External application, controls abscess of throat, and dispute is raw
Sore, the cataract triangular mass of mucous membrane growing from the inner corner of the eye, pudendal ulcer.
The embodiment of the present invention further relates to the preparation method of the Chinese medicine composition, comprising the following steps:
(1) by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng, smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan,
After Golden Larch Bark, cortex dictamni and chaulmoogra mixing, add water to cook to obtain medical fluid；
(2) borax is added into medical fluid, continues to boil, until medical fluid be condensed into it is spare after cream.
In one embodiment of the invention, the weight ratio of water and drug component is 1:(3~5).Such as plus dilutional hyponatremia, nothing
Method is brewed into paste.
In one embodiment of the invention, decocting step includes: that water is added into drug component to impregnate 2~3 hours
Afterwards, then fried 4~10 minutes of intense fire decoct with slow fire 80~120 minutes.
Further, which also contains following components according to parts by weight: 50~150 parts of sulphur, realgar
10~100 parts, 5~30 parts of camphor, 5~30 parts of borneol.
Sulphur also known as Sulfur are native element class mineral sulfur family sulphurite, or are made with containing sulfur minerals are processed.Sulphur
Containing elemental sulfur (S), plays the role of dissolving skin keratin and kill dermatozoon.There is killing to make dermatophyte and scabies, acarid
With, have removing toxic substances, desinsection, treat sore function.
Realgar is sulfide-based mineral realgar race realgar, the main (As containing realgar2S2).With removing toxic substances desinsection, eliminating dampness
The effect of eliminating the phlegm, preventing malaria.It is usually used in carbuncle swells furunculosis, snakebite and bugbite, abdominal pain due to enterositosis, frightened epilepsy, malaria.It causes a disease to common skin true
Bacterium has inhibiting effect.
Camphor, root, dry, branch, Ye Jingzheng for Lauraceae cinnamon camphor tree Cinnamomum camphora (L.) Presl.
Evaporate refined granular substance.Acrid flavour, it is warm-natured.Enter the heart, the spleen channel.With orifice opening, qi stagnation removing is warded off foul, and desinsection is antipruritic,
The effect of swelling and pain relieving.Pyreticosis coma is cured mainly, middle evil is dampinged off, acute filthy disease vomiting and diarrhoea abdominal pain, the disturbance of lower legs due to pathogenic cold and dampness, scabies stubborn dermatitis, the favus of the scalp, is frozen
Sore, ulcer on the shank, scald, injuries from falls as well, toothache, wind-fire red eye.
Borneol through steam distillation and is recrystallized and is obtained by composite family Blumea balsamifera cauline leaf or lauraceae plant borneol camphor tree branches and leaves.
Borneol is colorless and transparent or white translucent the crisp crystallization of sheet；Gas faint scent, it is acrid flavour, cool；Also useful turpentine oil is through a series of
Chemical method technique and obtain.It can be used for closing card coma, red eye, swell pain, and sore throat aphtha is used for sore swell and ache curative, not hold back after bursting.
Modern medicine proves that borneol has inhibiting effect to comma bacillus, Escherichia coli, staphylococcus aureus, there is inducing resuscitation of having one's ideas straightened out, clear
Hot pain-relieving functions.
In a preferred embodiment of the invention, Chinese medicine composition includes following components according to parts by weight: gold and silver
150 parts are spent, 150 parts of cordate houttuynia, 150 parts of spina gleditsiae, 150 parts of kuh-seng, 150 parts of smilax, 150 parts of Cortex Phellodendri, 150 parts of calamus, is ended
100 parts of leaf, 100 parts of Fructus Bruceae, 150 parts of Fructus meliae toosendan, 100 parts of Golden Larch Bark, 100 parts of cortex dictamni, 100 parts of chaulmoogra, borax 100
Part, 100 parts of sulphur, 60 parts of realgar, 15 parts of camphor, 15 parts of borneol.
The invention further relates to the preparation methods of the Chinese medicine composition, comprising the following steps:
(1) by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng, smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan,
After Golden Larch Bark, cortex dictamni and chaulmoogra mixing, add water to cook to obtain medical fluid；
(2) male sulphur, sulphur, borax, camphor and borneol after grinding are added into medical fluid, boils paste making agent.
In one embodiment of the invention, in step (1), the weight ratio of water and drug component is 1:(3~5).
In one embodiment of the invention, in step (2), after male sulphur, sulphur, borax, camphor and borneol and grinding,
Obtain partial size≤100 mesh particle.
In one embodiment of the invention, in step (2), decocting step includes: that water is added into drug component to impregnate
After 2~3 hours, intense fire fried 4~10 minutes, then decoct with slow fire 80~120 minutes.
In one particular embodiment of the present invention: in said medicine, first by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng,
After smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan, Golden Larch Bark, cortex dictamni and chaulmoogra remove impurity and foreign matter, add
The warm water for entering 3 times of drug weights impregnates 2 hours, then connects medicine band water and is transferred to a watt pot.It is first fried boiling with high heat 5 minutes, then with text
Fried 90 minutes of fire, filters to take to obtain medical fluid.The male sulphur after powder-refining with water is added into medical fluid, and by sulphur, borax, camphor, borneol
Smash it through 100 meshes also add it is into the liquid.By the medical fluid that male sulphur, sulphur, borax, camphor and borneol is added with decocting with slow fire
At ointment, which can be with chopsticks deduction silk.By the cooling bottling of ointment, seal spare.
The application method of the Chinese medicine composition is as follows: after just before going to bed cleaning affected part, take medical gloves, with middle finger or
Index finger takes this ointment appropriate, is applied directly to intravaginal or external affected part, can overbrushing smear several times, make ointment uniform fold.
Medication points for attention: 1, this drug is external preparation, not oral administration.2, medication again after affected part should being cleaned up.3,
It is not capable of washing in 8 hours after medication.4, serious patient, can increase times for spraying and dosage, for example, can early, evening or it is early,
In, evening is respectively using primary.
Embodiment 1
150 parts of extracting honeysuckle, 150 parts of cordate houttuynia, 150 parts of spina gleditsiae, 150 parts of kuh-seng, 150 parts of smilax, Cortex Phellodendri 150
Part, 150 parts of calamus, 100 parts of folium artemisiae argyi, 100 parts of Fructus Bruceae, 150 parts of Fructus meliae toosendan, 100 parts of Golden Larch Bark, 100 parts of cortex dictamni, strong wind
100 parts, 100 parts of borax, 100 parts of sulphur, 60 parts of realgar, 15 parts of camphor, 15 parts of borneol of son.The preparation method is as follows:
(1) by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng, smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan,
After Golden Larch Bark, cortex dictamni and chaulmoogra mixing, the water of 3 times of said medicine weight is added.It impregnates 2 hours, intense fire fried 4~
It 10 minutes, then decocts with slow fire 80~120 minutes, obtains medical fluid；
(2) male sulphur, sulphur, borax, camphor and the borneol of partial size≤100 after grinding, tanning after medical filtration, will be added
Paste making agent.
Embodiment 2
100 parts of extracting honeysuckle, 200 parts of cordate houttuynia, 100 parts of spina gleditsiae, 200 parts of kuh-seng, 100 parts of smilax, Cortex Phellodendri 200
Part, 100 parts of calamus, 50 parts of folium artemisiae argyi, 150 parts of Fructus Bruceae, 200 parts of Fructus meliae toosendan, 150 parts of Golden Larch Bark, 150 parts of cortex dictamni, chaulmoogra
100 parts, 100 parts of borax, 150 parts of sulphur, 60 parts of realgar, 5 parts of camphor, 5 parts of borneol.The preparation method is as follows:
(1) by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng, smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan,
After Golden Larch Bark, cortex dictamni and chaulmoogra mixing, the water of 3 times of said medicine weight is added.It impregnates 2 hours, intense fire fried 4~
It 10 minutes, then decocts with slow fire 80~120 minutes, obtains medical fluid；
(2) male sulphur, sulphur, borax, camphor and the borneol of partial size≤100 after grinding, tanning after medical filtration, will be added
Paste making agent.
Embodiment 3
150 parts of extracting honeysuckle, 150 parts of cordate houttuynia, 150 parts of spina gleditsiae, 150 parts of kuh-seng, 150 parts of smilax, Cortex Phellodendri 150
Part, 150 parts of calamus, 100 parts of folium artemisiae argyi, 100 parts of Fructus Bruceae, 150 parts of Fructus meliae toosendan, 100 parts of Golden Larch Bark, 100 parts of cortex dictamni, strong wind
100 parts, 100 parts of borax of son.The preparation method is as follows:
(1) by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng, smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan,
After Golden Larch Bark, cortex dictamni and chaulmoogra mixing, the water of 3 times of said medicine weight is added.It impregnates 2 hours, intense fire fried 4~
It 10 minutes, then decocts with slow fire 80~120 minutes, obtains medical fluid；
(2) by after medical filtration, the borax of partial size≤100 after grinding is added, continues to boil paste making agent.
Clinical effectiveness
Between 2008-2018, applicant uses the Chinese medicine composition of embodiment 1, sees and treat patients and treats gynaecology patient
36980 people, wherein effectively be greater than 35600 people, responder's standard with modern medical service inspection result be with.Effective standard is with the modern times
Medical examination result be with.Clinical cure standard with modern medical service inspection result be with.The effective percentage of the composition is higher than
82%, obvious effective rate is higher than 67%, and cure rate is higher than 62%.
For the Chinese medicine composition of embodiment 2, effective percentage is higher than 80%, and obvious effective rate is higher than 65%, and cure rate is higher than
60%.
For the Chinese medicine composition of embodiment 3, effective percentage is higher than 77%, and obvious effective rate is higher than 60%, and cure rate is higher than
55%.
Typical case
1, poplar, female 45 years old, suffer from vaginitis, pruritus vulvue more than 10 year.Using symptom after lotion or oral medicine treatment
It is improved, but is recurred after being discontinued.External application is carried out using example 1 drug, once a day.Remission after 7 days, two
It is cured after month.Follow-up is not recurred after 1 year.
2, Lee, female, 36 years old, colpomycosis patient, secretion was in bean dregs shape.Using the drug of embodiment 1, often
It is smeared twice.Symptom mitigates after two weeks, cures after 3 months.
3, Liu, female 41 years old, suffer from pelvic inflammatory disease throughout the year, cannot stand long or sitting.Using the drug of embodiment 2, apply daily
It smears twice.Symptom mitigates after 1 week, cures after 2 months.
The above description is merely a specific embodiment, but scope of protection of the present invention is not limited thereto, appoints
What those familiar with the art in the technical scope disclosed by the present invention, can easily think of the change or the replacement, answer
It is included within the scope of the present invention.Therefore, protection scope of the present invention should be with the scope of protection of the claims
It is quasi-.
Claims (10)
1. a kind of for treating the Chinese medicine composition of gynaecological disease, which is characterized in that including following components according to parts by weight: gold
100~200 parts of honeysuckle flower, 100~200 parts of cordate houttuynia, 100~200 parts of spina gleditsiae, 100~200 parts of kuh-seng, smilax 100~
200 parts, 100~200 parts of Cortex Phellodendri, 100~200 parts of calamus, 50~150 parts of folium artemisiae argyi, 50~150 parts of Fructus Bruceae, Fructus meliae toosendan 100~
200 parts, 50~150 parts of Golden Larch Bark, 50~150 parts of cortex dictamni, 50~150 parts of chaulmoogra, 50~150 parts of borax.
2. the preparation method of Chinese medicine composition according to claim 1, which comprises the following steps:
(1) by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng, smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan, native chaste tree
After skin, cortex dictamni and chaulmoogra mixing, add water to cook to obtain medical fluid；
(2) borax is added in Xiang Suoshu medical fluid, continues to boil paste making agent.
3. the preparation method of Chinese medicine composition according to claim 2, which is characterized in that the weight of the water and drug component
Than for 1:(3~5).
4. the preparation method of Chinese medicine composition according to claim 2, which is characterized in that the decoction step includes: to medicine
After water immersion being added in object component 2~3 hours, intense fire fried 4~10 minutes, then decoct with slow fire 80~120 minutes.
5. Chinese medicine composition according to claim 1, which is characterized in that the Chinese medicine composition also contains according to parts by weight
Following components: 50~150 parts of sulphur, 10~100 parts of realgar, 5~30 parts of camphor, 5~30 parts of borneol.
6. Chinese medicine composition according to claim 5, which is characterized in that the Chinese medicine composition includes according to parts by weight
Following components: 150 parts of honeysuckle, 150 parts of cordate houttuynia, 150 parts of spina gleditsiae, 150 parts of kuh-seng, 150 parts of smilax, 150 parts of Cortex Phellodendri,
150 parts of calamus, 100 parts of folium artemisiae argyi, 100 parts of Fructus Bruceae, 150 parts of Fructus meliae toosendan, 100 parts of Golden Larch Bark, 100 parts of cortex dictamni, chaulmoogra 100
Part, 100 parts of borax, 100 parts of sulphur, 60 parts of realgar, 15 parts of camphor, 15 parts of borneol.
7. according to the preparation method of the Chinese medicine composition of claim 5 or 6, which comprises the following steps:
(1) by honeysuckle, cordate houttuynia, spina gleditsiae, kuh-seng, smilax, Cortex Phellodendri, calamus, folium artemisiae argyi, Fructus Bruceae, Fructus meliae toosendan, native chaste tree
After skin, cortex dictamni and chaulmoogra mixing, add water to cook to obtain medical fluid；
(2) male sulphur, sulphur, borax, camphor and borneol after grinding are added in Xiang Suoshu medical fluid, boils paste making agent.
8. the preparation method of Chinese medicine composition according to claim 7, which is characterized in that the weight of the water and drug component
Than for 1:(3~5).
9. the preparation method of Chinese medicine composition according to claim 7, which is characterized in that by the male sulphur, sulphur, borax,
After camphor and borneol and grinding, partial size≤100 mesh particle is obtained.
10. the preparation method of Chinese medicine composition according to claim 7, which is characterized in that the decoction step includes: to medicine
After water immersion being added in object component 2~3 hours, intense fire fried 4~10 minutes, then decoct with slow fire 80~120 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811547107.2A CN109432275A (en) | 2018-12-18 | 2018-12-18 | A kind of Chinese medicine composition and preparation method thereof for treating gynaecological disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811547107.2A CN109432275A (en) | 2018-12-18 | 2018-12-18 | A kind of Chinese medicine composition and preparation method thereof for treating gynaecological disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109432275A true CN109432275A (en) | 2019-03-08 |
Family
ID=65558833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811547107.2A Pending CN109432275A (en) | 2018-12-18 | 2018-12-18 | A kind of Chinese medicine composition and preparation method thereof for treating gynaecological disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109432275A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1178690A (en) * | 1997-09-24 | 1998-04-15 | 阎康会 | Gynecological external use capsule |
| CN1739754A (en) * | 2005-09-16 | 2006-03-01 | 马海龙 | Lotion for treating mycotic vaginitis |
-
2018
- 2018-12-18 CN CN201811547107.2A patent/CN109432275A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1178690A (en) * | 1997-09-24 | 1998-04-15 | 阎康会 | Gynecological external use capsule |
| CN1739754A (en) * | 2005-09-16 | 2006-03-01 | 马海龙 | Lotion for treating mycotic vaginitis |
Non-Patent Citations (1)
| Title |
|---|
| 张海莹等: "外治法在妇科临床上的运用", 《长春中医学院学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101804166B (en) | Traditional Chinese medicine composition for treating dermatitis and eczema of infants | |
| CN102091203B (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
| KR101352445B1 (en) | A method for manufacturing the composition for treating wemen's disease | |
| CN103751663B (en) | A kind of Chinese medicine for external application treating anal eczema and preparation method thereof | |
| CN104398934A (en) | Traditional Chinese medicine combination for treating cutaneous pruritus and preparation method thereof | |
| CN101518600B (en) | Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof | |
| CN102178877A (en) | External preparation for treating eczema of scrotum and preparation method thereof | |
| CN107737229A (en) | Prevent and treat Chinese herbal feed additive of swine flu and preparation method thereof | |
| CN104940886A (en) | External preparation for treating seborrheic alopecia and preparing method thereof | |
| CN103721138A (en) | External traditional Chinese medicinal preparation for treating acne rosacea and preparation method thereof | |
| CN104435505A (en) | Enema for treating proctitis and preparation method of enema | |
| CN107213225A (en) | A kind of pharmaceutical composition and its application for being used to relieving pain, promoting bone uptake | |
| CN109432275A (en) | A kind of Chinese medicine composition and preparation method thereof for treating gynaecological disease | |
| CN103977115B (en) | A kind of treat outer Chinese medicine for outer use injuring infection and preparation method thereof | |
| CN112022947A (en) | Bacteriostatic agent based on traditional Chinese herbal medicines and small molecular compounds, and preparation method and application thereof | |
| CN105250525A (en) | Traditional Chinese medicine lotion for treating diabetic foot and preparation method thereof | |
| CN105106591A (en) | Bovine pulmonary edema treatment medicine and preparation method thereof | |
| CN104510815B (en) | Prevent and treat the Chinese medicine preparation of pork pig dermatitis | |
| CN104547794A (en) | Traditional Chinese medicine composition for treating bone fracture | |
| CN104096139A (en) | Chinese medicinal preparation for treating metal mercury poisoning | |
| CN103432565A (en) | Gynaecological antiphlogistic and analgesic pharmaceutical formulation | |
| CN106110193A (en) | A kind of external skin ulcer convergence ointment and compound method thereof | |
| CN105943646A (en) | Multifunctional traditional Chinese medicine liquid capable of achieving disinfection, killing germs and stopping bleeding | |
| CN104645157A (en) | External application agent for removing burns and scalds scars and preparation method of external application agent | |
| CN105267457A (en) | Traditional Chinese medicine preparation for treating neonatal diaper dermatitis and method for preparing traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190308 |